Cargando…

Significance of gut microbiota in alcoholic and non-alcoholic fatty liver diseases

Liver-gut communication is vital in fatty liver diseases, and gut microbes are the key regulators in maintaining liver homeostasis. Chronic alcohol abuse and persistent overnutrition create dysbiosis in gut ecology, which can contribute to fatty liver disease. In this review, we discuss the gut micr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Satya Priya, Suk, Ki Tae, Kim, Dong Joon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Frontier
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515797/ https://www.ncbi.nlm.nih.gov/pubmed/34712025 http://dx.doi.org/10.3748/wjg.v27.i37.6161

Ejemplares similares

Acetyl-CoA carboxylase inhibitors in non-alcoholic steatohepatitis: Is there a benefit?
por: Neokosmidis, Georgios, et al.
Publicado: (2021)

Gut Microbiota at the Intersection of Alcohol, Brain, and the Liver
por: Gupta, Haripriya, et al.
Publicado: (2021)

The convergent application of metabolites from Avena sativa and gut microbiota to ameliorate non-alcoholic fatty liver disease: a network pharmacology study
por: Oh, Ki-Kwang, et al.
Publicado: (2023)

Gut-liver axis in cirrhosis: Are hemodynamic changes a missing link?
por: Maslennikov, Roman, et al.
Publicado: (2021)

Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases
por: Park, Ji-Won, et al.
Publicado: (2021)

Gut microbiota-modulating agents in alcoholic liver disease: Links between host metabolism and gut microbiota
por: Jung, Jang Han, et al.
Publicado: (2022)

Antimicrobial peptides and the gut microbiome in inflammatory bowel disease
por: Gubatan, John, et al.
Publicado: (2021)

Non-alcoholic fatty liver and the gut microbiota
por: Bashiardes, Stavros, et al.
Publicado: (2016)

Gut Microbiome in Non-Alcoholic Fatty Liver Disease: From Mechanisms to Therapeutic Role
por: Gupta, Haripriya, et al.
Publicado: (2022)

Gut microbiome and pancreatic cancer cachexia: An evolving relationship
por: Hendifar, Andrew, et al.
Publicado: (2022)

The juxtaposition of Ilex cornuta fruit and gut microbiota against alcoholic liver disease based on the integrated pharmacology via metabolomics
por: Oh, Ki‐Kwang, et al.
Publicado: (2023)

Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21(st) century
por: El-Salhy, Magdy, et al.
Publicado: (2021)

Gut Microbiota-Related Cellular and Molecular Mechanisms in the Progression of Nonalcoholic Fatty Liver Disease
por: Park, Eunju, et al.
Publicado: (2021)

Imaging of the chemotherapy-induced hepatic damage: Yellow liver, blue liver, and pseudocirrhosis
por: Calistri, Linda, et al.
Publicado: (2021)

Engineering nanotheranostic strategies for liver cancer
por: Cao, Lei, et al.
Publicado: (2021)

Liver dysfunction and SARS-CoV-2 infection
por: Gracia-Ramos, Abraham Edgar, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease, diet and gut microbiota
por: Finelli, Carmine, et al.
Publicado: (2014)

Chronic rejection after liver transplantation: Opening the Pandora’s box
por: Angelico, Roberta, et al.
Publicado: (2021)

New era of electrochemotherapy in treatment of liver tumors in conjunction with immunotherapies
por: Trotovšek, Blaž, et al.
Publicado: (2021)

Long-term survival outcome of laparoscopic liver resection for hepatocellular carcinoma
por: Lam, Shi, et al.
Publicado: (2021)

Eliminating viral hepatitis in children after liver transplants: How to reach the goal by 2030
por: Sintusek, Palittiya, et al.
Publicado: (2022)

Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease
por: Zhou, Jin, et al.
Publicado: (2021)

Ranking non-pharmaceutical interventions against Covid-19 global pandemic using global sensitivity analysis—Effect on number of deaths
por: Hanthanan Arachchilage, Kalpana, et al.
Publicado: (2021)

Palmitoylation in Crohn’s disease: Current status and future directions
por: Cheng, Wei-Xin, et al.
Publicado: (2021)

Food and Gut Microbiota-Derived Metabolites in Nonalcoholic Fatty Liver Disease
por: Jeong, Min Kyo, et al.
Publicado: (2022)

Identification of Gut Microbiome Metabolites via Network Pharmacology Analysis in Treating Alcoholic Liver Disease
por: Oh, Ki-Kwang, et al.
Publicado: (2022)

The Gut Microbiota-Derived Immune Response in Chronic Liver Disease
por: Won, Sung-Min, et al.
Publicado: (2021)

Causative role of gut microbiota in non-alcoholic fatty liver disease pathogenesis
por: Alisi, Anna, et al.
Publicado: (2012)

The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms
por: JASIRWAN, Chyntia Olivia Maurine, et al.
Publicado: (2019)

Disentangling the Progression of Non-alcoholic Fatty Liver Disease in the Human Gut Microbiota
por: Wang, Tianjiao, et al.
Publicado: (2021)

Gut microbiota–mitochondrial inter-talk in non-alcoholic fatty liver disease
por: Zhang, Qi, et al.
Publicado: (2022)

Effect of vaccine efficacy on disease transmission with age-structured
por: Yin, Lu, et al.
Publicado: (2022)

Biomarkers in autoimmune pancreatitis and immunoglobulin G4-related disease
por: Hara, Akane, et al.
Publicado: (2021)

Colorectal cancer screening and surveillance in patients with inflammatory bowel disease in 2021
por: Huguet, Jose Maria, et al.
Publicado: (2022)

Treatment repurposing for inflammatory bowel disease using literature-related discovery and innovation
por: Kostoff, Ronald Neil, et al.
Publicado: (2020)

Orphan patients with inflammatory bowel disease - when we treat beyond evidence
por: Privitera, Giuseppe, et al.
Publicado: (2021)

5-Aminosalicylates to maintain remission in Crohn’s disease: Interpreting conflicting systematic review evidence
por: Gordon, Morris
Publicado: (2017)

Multifractal analysis of chest CT images of patients with the 2019 novel coronavirus disease (COVID-19)
por: Astinchap, Bandar, et al.
Publicado: (2022)

A numerical simulation of fractional order mathematical modeling of COVID-19 disease in case of Wuhan China
por: Yadav, Ram Prasad, et al.
Publicado: (2020)

Investigating a nonlinear dynamical model of COVID-19 disease under fuzzy caputo, random and ABC fractional order derivative
por: Rahman, Mati ur, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_oi2rbq830hfu7hjt1u8cc2161n